150 related articles for article (PubMed ID: 6582585)
1. Combined granulocyte and platelet transfusions: inter-relationship between granulocyte and platelet recoveries in the presence and absence of complicating factors.
Ford JM; Cullen MH; Brown LM; Roberts MM; Fulford AJ; Lister TA
Scand J Haematol; 1984 Jan; 32(1):65-75. PubMed ID: 6582585
[TBL] [Abstract][Full Text] [Related]
2. Combined granulocyte and platelet transfusions. Development of alloimmunization as reflected by decreasing cell recovery values.
Ford JM; Brown LM; Cullen MH; Oliver RT; Wadsworth J; Lister TA
Transfusion; 1982; 22(6):498-503. PubMed ID: 6959405
[TBL] [Abstract][Full Text] [Related]
3. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE
Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314
[TBL] [Abstract][Full Text] [Related]
4. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
Lee EJ; Schiffer CA
Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
[TBL] [Abstract][Full Text] [Related]
5. Current status of leukocyte and platelet administration in cancer therapy.
Walker EM; Cannon A; Mitchum EN
Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous gamma globulin to suppress alloimmune destruction of donor platelets.
Junghans RP; Ahn YS
Am J Med; 1984 Mar; 76(3A):204-8. PubMed ID: 6424453
[TBL] [Abstract][Full Text] [Related]
7. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
[TBL] [Abstract][Full Text] [Related]
8. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial.
Enright H; Davis K; Gernsheimer T; McCullough JJ; Woodson R; Slichter SJ
Transfusion; 2003 Nov; 43(11):1545-52. PubMed ID: 14617313
[TBL] [Abstract][Full Text] [Related]
10. Cryopreserved autologous platelet transfusions in alloimmunized patients with acute leukemia.
Wiesneth M; Koerner K; Funke I; Seifried E; Cardoso M; Heimpel H; Kubanek B
Beitr Infusionsther; 1992; 30():297-300. PubMed ID: 1284720
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia.
Lowenthal RM; Grossman L; Goldman JM; Storring RA; Buskard NA; Park DS; Murphy BC; Spiers AS; Galton DA
Lancet; 1975 Feb; 1(7903):353-8. PubMed ID: 46510
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions.
Waterman HR; Kapp LM; Munday A; Odem-Davis K; Zimring JC
Transfusion; 2016 Jan; 56(1):91-100. PubMed ID: 26400622
[TBL] [Abstract][Full Text] [Related]
13. Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets.
Muench MO; Heitman JW; Inglis H; Fomin ME; Marschner S; Goodrich RP; Norris PJ; Jackman RP
Transfusion; 2016 Jun; 56(6):1419-29. PubMed ID: 27028210
[TBL] [Abstract][Full Text] [Related]
14. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
[TBL] [Abstract][Full Text] [Related]
15. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K; Löwenberg B
Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT
Ladaique P; Etienne JM; Pedini P; Chiaroni J; Vey N; Picard C; Chabrieres C
Blood Transfus; 2023 Sep; 21(5):400-408. PubMed ID: 36795348
[TBL] [Abstract][Full Text] [Related]
17. ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets.
Yazer MH; Raval JS; Triulzi DJ; Blumberg N
Vox Sang; 2012 Feb; 102(2):175-7. PubMed ID: 21781126
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates.
McFarland JG; Anderson AJ; Slichter SJ
Br J Haematol; 1989 Nov; 73(3):380-6. PubMed ID: 2605125
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with transfusion of leukocyte-poor platelet concentrates prepared by filtration with prostacyclin.
van Prooijen HC; Riemens TI; Akkerman JW
Blood; 1987 Jul; 70(1):243-6. PubMed ID: 3297202
[TBL] [Abstract][Full Text] [Related]
20. Alloimmune platelet transfusion refractoriness circumvented by allogeneic stem cell transplantation.
Bonstein L; Stemer G; Dann EJ; Zuckerman T; Fineman R; Haddad N
Transfusion; 2013 May; 53(5):1019-23. PubMed ID: 22897696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
